廣康生化(300804.SZ):部分特定股東擬合計減持不超3%股份
格隆匯6月3日丨廣康生化(300804.SZ)公佈,公司的股東共青城華拓至盈貳號投資合夥企業(有限合夥)目前持有公司股份1,350,000股(佔公司總股本比例1.8243%);深圳市華拓至遠投資企業(有限合夥)目前持有公司股份800,000股(佔公司總股本比例1.0811%);深圳市華拓至遠貳號投資企業(有限合夥)目前持有公司股份750,000股(佔公司總股本比例1.0135%);深圳市華拓至遠叄號投資企業(有限合夥)目前持有公司股份650,000股(佔公司總股本比例0.8784%)。根據《廣東廣康生化科技股份有限公司首次公開發行股票並在創業板上市招股說明書》,上述股東因共同的基金管理人(執行事務合夥人)爲深圳市華拓私募股權投資基金管理有限公司,合併計算股份比例,合併計算後上述股東合計持有公司股份3,550,000股(佔公司總股本比例4.7973%)。
現上述股東計劃自公告披露日起的3個交易日後的3個月內通過集中競價、大宗交易方式合計減持公司股份不超過2,220,000股,即不超過公司總股本的3.00%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.